Similar articles

• [Therapy of hypertension. Lasting organ protection moves into the foreground].

  [No authors listed] [No authors listed] MMW Fortschr Med. 2003 Nov 20;145(47):62. MMW Fortschr Med. 2003. PMID: 14738040 German. No abstract available.
• [Despite drug treatment, ever second hypertensive patient with morning blood pressure too high].

  [No authors listed] [No authors listed] MMW Fortschr Med. 2004 Aug 19;146(33-34):52. MMW Fortschr Med. 2004. PMID: 15526635 German. No abstract available.
• Telmisartan provides superior BP reduction from morning to morning compared to other leading ARBs.

  [No authors listed] [No authors listed] Cardiovasc J S Afr. 2006 Jul-Aug;17(4):210. Cardiovasc J S Afr. 2006. PMID: 17001428 No abstract available.
• [Telmisartan (micardis) -- an antagonist of angiotensin 2 of type 1 receptors: another antihypertensive drug or something greater?].

  Chazova IE. Chazova IE. Ter Arkh. 2003;75(6):89-91. Ter Arkh. 2003. PMID: 12920969 Review. Russian. No abstract available.
• Telmisartan plus amlodipine single-pill combination for the management of hypertensive patients with a metabolic risk profile (added-risk patients).

  Ley L, Schumacher H. Ley L, et al. Curr Med Res Opin. 2013 Jan;29(1):41-53. doi: 10.1185/03007995.2012.750601. Epub 2012 Dec 6. Curr Med Res Opin. 2013. PMID: 23157465 Review.